Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Pharmacology Biochemistry and Behavior • 2003 | View Paper
“Recently, we reported that naltrexone at 150 mg/day significantly decreased cocaine and alcohol use for men but not women with co-occurring cocaine and alcohol dependence.”
The American journal on addictions • 2008 | View Paper
“Thus, 150 mg/day naltrexone added to a psychosocial treatment resulted in reductions in cocaine and alcohol use and drug severity in men, compared to higher rates of cocaine and alcohol use and drug severity in women.”
Journal of substance abuse treatment • 2008 | View Paper
“Conclusion: Both NTX and NMF block the place preference, but not locomotor activating, effects of cocaine.”
“Several preclinical and clinical studies have demonstrated that the mu opioid receptor (MOPr) antagonist/kappa opioid receptor (KOPr) partial agonist naltrexone (NTX) reduces the subjective effects and self‐administration of cocaine.”
“However, pretreatment with GYKI 52466 or naltrexone at doses that suppressed conditioned activity in FR animals suppressed cross-sensitization to cocaine.”
“When administered alone, cocaine and amphetamine increased respiration and also increased the respiratory stimulant effects of naltrexone ; cocaine and amphetamine did not attenuate any measure of withdrawal.”
“Pretreatments with naltrexone (0.1–10 mg/kg, SC) 20 min prior to the start of self-administration sessions resulted in decreases in cocaine self-administration at doses of 0.1 and 0.3 mg/kg/infusion, but not at 1.0 mg/kg/infusion.”
“ Cocaine and amphetamine antagonized the discriminative stimulus effects of naltrexone , each shifting the naltrexone dose-effect curve significantly (e.g., 100-fold) rightward or downward.”